Skip to content

Clinical trials

Completed Adenocarcinoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20053
20061
20071
20082
20093
20103
20111
20122
20141
20151
20162
20171
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Nottingham University Hospitals NHS Trust2
Abbott1
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Celgene1
Clovis Oncology, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma24
Carcinoma, Non-Small-Cell Lung7
Carcinoma4
Colorectal Neoplasms4
Lung Neoplasms4
Neoplasm Metastasis4
Neoplasms4
Stomach Neoplasms4
Carcinoma, Squamous Cell3
Esophageal Neoplasms3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.